original ) (raw )Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Peter Neuhaus
Journal of Hepatology, 2004
View PDFchevron_right
Impact of Fibrosis Progression on Clinical Outcome in Patients Treated for Post- Transplant Hepatitis C Recurrence
William Sanchez
Liver international : official journal of the International Association for the Study of the Liver, 2015
View PDFchevron_right
Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment
Detlef Schuppan
Journal of Hepatology, 2013
View PDFchevron_right
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
Jonathan Shuster
Liver Transplantation, 2004
View PDFchevron_right
Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study
Patrizia Burra
Digestive and Liver Disease, 2012
View PDFchevron_right
Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C
Rolland Dickson
Liver Transplantation, 2008
View PDFchevron_right
Serum Fibrosis Markers Identify Patients With Mild and Progressive Hepatitis C Recurrence After Liver Transplantation
Guillermo Fernández-varo
Gastroenterology, 2010
View PDFchevron_right
Histologic Predictors of Fibrosis Progression in Liver Allografts in Patients With Hepatitis C Virus Infection
Kimberly Forde
Clinical Gastroenterology and Hepatology, 2010
View PDFchevron_right
Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods
Mona Amir
Clinical transplantation, 2018
View PDFchevron_right
Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis
Faouzi Saliba
Liver Transplantation, 2008
View PDFchevron_right
Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-Infected Patients
Michel Scotte
The American Journal of Pathology, 2009
View PDFchevron_right
Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C
Bulent Baban
Journal of Viral Hepatitis, 2013
View PDFchevron_right
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus
Norah Terrault
Liver Transplantation, 2011
View PDFchevron_right
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
Hesty Wali
Gut, 2002
View PDFchevron_right
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
Irene Carmona Cuenca
Clinical Microbiology and Infection, 2016
View PDFchevron_right
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection
Jean-Pierre Vinel
Gastroenterology, 2002
View PDFchevron_right
Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection
H. Schmilovitz-weiss
Clinical Transplantation, 2007
View PDFchevron_right
Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review
Wojciech Lisik
Transplantation Proceedings, 2017
View PDFchevron_right
Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation
Ferran Torres
Hepatology, 2009
View PDFchevron_right
Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence
Bulent Baban
Clinical Gastroenterology and Hepatology, 2010
View PDFchevron_right
Risk factors for hepatitis C recurrence after liver transplantation
Bruno Roche
Journal of Viral Hepatitis, 2007
View PDFchevron_right
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age
George Therapondos
Liver Transplantation, 2008
View PDFchevron_right
Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
Andrew Ma
Viruses, 2021
View PDFchevron_right
Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence
Raquel Lorente
Transplant Infectious Disease, 2009
View PDFchevron_right
Early Identification of Recipients With Progressive Histologic Recurrence of Hepatitis C After Liver Transplantation
Russell Wiesner , Charles Rosen
Hepatology, 2000
View PDFchevron_right
Risk factors for recurrence of hepatitis C after liver transplantation
NICOLAS GARCIA
Liver Transplantation and Surgery, 1998
View PDFchevron_right
Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation
Amiee Potter
Liver Transplantation, 2011
View PDFchevron_right
Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation
Rosa Miquel
Journal of Hepatology, 2014
View PDFchevron_right
A novel hypothesis for pathophysiology of hepatitis fibrosis in hepatitis C viral infection
Sherif Salah
Hypothesis, 2011
View PDFchevron_right
Correlation Between Liver Fibrosis and Inflammation in Patients Transplanted for HCV Liver Disease
M. Carbone
American Journal of Transplantation, 2008
View PDFchevron_right
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
Giuseppe Orlando
Transplant International, 2011
View PDFchevron_right